• NAV per share increased by 9% in the first half of 2024, compared to 14% of the MSCI World Index, mainly
driven by the performance of Ferrari, Philips and Lingotto Funds.

• Strong cash flow generation with dividends received from Companies and asset disposals of €1.5 billion.
Cash deployed into Companies, Investments and share buybacks amounted to €1.1 billion, maintaining a
disciplined capital allocation.

• Net debt was €3.7 billion at 30 June 2024 from €4.0 billion at 1 January 2024, with an LTV ratio of 9%.

Exor N.V. informs that the Board of Directors meeting called for the approval of the 2024 Half-Year Financial Report, originally scheduled for Wednesday 25 September 2024, has been rescheduled to Tuesday 24 September 2024.

An updated version of the Corporate Calendar is available on Exor’s website, under the 2024 Corporate Calendar section.

Exor N.V. (the “Company”) announces today its intention to continue the share buyback program announced on 13 September 2023 (the “Program”) for the remaining amount of up to € 250 million of ordinary shares to reduce Exor’s share capital in line with the announcement made on 13 September 2023.

Exor N.V. (“Exor” or the “Company”) announces that all the resolutions proposed by the Board of Directors to the Annual General Meeting of Shareholders (the “AGM”) held today in Amsterdam were approved.

The AGM adopted Exor’s 2023 annual accounts and approved a dividend distribution of €0.46 per outstanding share, for a total of approximately €100 million. The dividend will become payable on 3 June 2024 (ex-dividend date 30 May 2024) and will be paid to the shareholders of record as of 31 May 2024 (record date).

Exor N.V. (the “Company”) announces today that it will restart the share buyback program announced on 13 September 2023 (the “Program”) for the remaining amount of up to € 250 million of ordinary shares to reduce Exor’s share capital in line with the announcement made on 13 September 2023.

The Company will start on 15 April 2024 with a first tranche of purchases up to €125 million, which is expected to complete by September 2024, or earlier if the maximum amount has been reached (the "First Tranche").

• NAV reached €35.5 billion at 31 December 2023 with NAV per share increasing by 32.7%, outperforming the MSCI World Index by 15.1 p.p.

Clarivate and Exor Sign Agreement Under Which Suzanne Heywood Will Be Nominated to Stand for Election to the Company’s Board of Directors

Exor becomes a long-term investor in Clarivate, endorsing the strategic direction set out by the Company’s Management and Board, and announces it now has a 10.1% shareholding in the Company and can increase its participation up to 17.5%